Click here to view abstracts and links to the full text of all publications from the APC, or on the citation below.
Joseph JI, Hipszer B. Real-time glucose monitoring in the hospital: future or now? Adv Surg 44:165-84, 2010
Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI.
Preadmission hyperglycemia is an independent risk factor for in-hospital
symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty 25:64-70, 2010
Steil GM, Hipszer B, Reifman J. Update on mathematical modeling research to support the development of automated insulin delivery systems. J Diabetes Sci
Technol 4:759-769, 2010
Joseph JI, Hipszer B, Mraovic B, Chervoneva I, Joseph M, Grunwald Z. Clinical
need for continuous glucose monitoring in the hospital. J Diabetes Sci Technol
3:1309-1318, 2009
Mraovic B. Analysis: Continuous glucose monitoring during intensive insulin
therapy. J Diabetes Sci Technol 2009 3:960-963, 2009
Ryan MT, Savarese VW, Hipszer B, Dizdarevic I, Joseph M, Shively N, Joseph JI. Continuous glucose monitor shows potential for early hypoglycemia detection in
hospitalized patients. Diabetes Technol Ther 11:745-747, 2009
Loboda A, Kraft WK, Fine B, Joseph J, Nebozhyn M, Zhang C, He Y, Yang X,
Wright C, Morris M, Chalikonda I, Ferguson M, Emilsson V, Leonardson A, Lamb J,
Dai H, Schadt E, Greenberg HE, Lum PY. Diurnal variation of the human adipose
transcriptome and the link to metabolic disease. BMC Med Genomics 2:7, 2009
Tuesca AD, Reiff C, Joseph JI, Lowman AM. Synthesis, characterization and in
vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels.
Pharm Res 26:727-739, 2009
Simon B, Treat V, Marco C, Rosenberg D, Joseph J, Hipszer B, Li Y, Chervoneva
I, Padron-Massara L, Jabbour S. A comparison of glycaemic variability in CSII vs.
MDI treated type 1 diabetic patients using CGMS. Int J Clin Pract 62:18581-1863, 2008
Tuesca A, Nakamura K, Morishita M, Joseph J, Peppas N, Lowman A. Complexation
hydrogels for oral insulin delivery: effects of polymer dosing on in vivo
efficacy. J Pharm Sci 97:2607-2618, 2008
Beilman GJ, Joseph JI. Practical considerations for glucose control in
hospitalized patients. Diabetes Technol Ther 7:823-830, 2005
Hipszer B, Joseph J, Kam M. Pharmacokinetics of intravenous insulin delivery
in humans with type 1 diabetes. Diabetes Technol Ther 7:83-93, 2005
Morishita M, Goto T, Peppas NA, Joseph JI, Torjman MC, Munsick C, Nakamura K,
Yamagata T, Takayama K, Lowman AM. Mucosal insulin delivery systems based on
complexation polymer hydrogels: effect of particle size on insulin enteral
absorption. J Control Release 97:115-24, 2004
Weihrauch D, Lohr NL, Mraovic B, Ludwig LM, Chilian WM, Pagel PS, Warltier
DC, Kersten JR. Chronic hyperglycemia attenuates coronary collateral development
and impairs proliferative properties of myocardial interstitial fluid by
production of angiostatin. Circulation 109:2343-2348, 2004
Nakamura K, Murray RJ, Joseph JI, Peppas NA, Morishita M, Lowman AM. Oral
insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on
insulin delivery characteristics. J Control Release 95:589-599, 2004
